Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care

Published:2014-05-22 Issue:6 Volume:77 Page:1073-1082
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Payne Rupert A.¹,Abel Gary A.¹,Avery Anthony J.²,Mercer Stewart W.³,Roland Martin O.¹

Affiliation:

1. Cambridge Centre for Health Services Research; Institute of Public Health; University of Cambridge; Cambridge CB2 0SR UK

2. Division of Primary Care; University of Nottingham Medical School; Nottingham NG7 2UH UK

3. General Practice and Primary Care; University of Glasgow; Glasgow G12 9LX UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12292/fullpdf

Reference32 articles.

1. Polypharmacy and prescribing quality in older people;Steinman;J Am Geriatr Soc,2006

2. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008;Hovstadius;BMC Clin Pharmacol,2010

3. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study;Barnett;Lancet,2012

4. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance;Boyd;JAMA,2005

5. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice;Guthrie;BMJ,2011

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial;The European Journal of Health Economics;2024-08-27

2. Exploring the heterogeneity in community pharmacist-led medication review studies – A systematic review;Research in Social and Administrative Pharmacy;2024-08

3. Protocol for the development and validation of a Polypharmacy Assessment Score;Diagnostic and Prognostic Research;2024-07-16

4. Factors associated with potentially inappropriate prescribing in elderly patients with various degrees of chronic kidney disease;Hemodialysis International;2024-07-03

5. Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study;International Journal of Clinical Pharmacy;2024-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3